TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The 1st Annual EmpowerHER Women’s Health Summit, hosted by Bridge Medical Communications, will…
New approach enables broad, simple and affordable access to trusted scholarly content for learning and research LONDON, Feb. 18, 2025…
Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first…
NEW YORK and BENGALURU, India, Jan. 13, 2025 /PRNewswire/ -- Tredence, a leading data science and AI solutions provider, announced…
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/…
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/…
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/…
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/…
SINGAPORE, Dec. 4, 2024 /PRNewswire/ -- McCann Worldgroup has launched its latest insights study, the Truth about Ascending Asia, at…
SINGAPORE, Dec. 4, 2024 /PRNewswire/ -- McCann Worldgroup has launched its latest insights study, the Truth about Ascending Asia, at…
